Riffle Stephen, Pandey Ram Naresh, Albert Morgan, Hegde Rashmi S
Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA.
BMC Cancer. 2017 May 18;17(1):338. doi: 10.1186/s12885-017-3319-0.
Multicellular Tumor Spheroids are frequently used to mimic the regionalization of proliferation and the hypoxic environment within avascular tumors. Here we exploit these features to study the activation of DNA damage repair pathways and their correlation to developing hypoxia.
Activation of DNA damage repair markers, proliferation, cell death, glycogen accumulation and developing hypoxia were investigated using immunofluorescence, immuno-histochemistry, EdU incorporation, Western blots, COMET assays, and pharmacological agents in A673 Ewing sarcoma spheroids and monolayer cultures.
DNA damage marker γ-H2AX is observed in the hypoxic, peri-necrotic region of growing spheroids. While most proliferating cells are seen on the spheroid surface, there are also a few Ki-67 positive cells in the hypoxic zone. The hypoxia-induced phosphorylation of H2AX to form γ-H2AX in spheroids is attenuated by the ATM inhibitor KU55933, but not the ATR inhibitor VE-821.
Tumor spheroids mimic tumor microenvironments such as the anoxic, hypoxic and oxic niches within solid tumors, as well as populations of cells that are viable, proliferating, and undergoing DNA damage repair processes under these different micro-environmental conditions. ATM, but not ATR, is the primary kinase responsible for γ-H2AX formation in the hypoxic core of A673 spheroids. Spheroids could offer unique advantages in testing therapeutics designed to target malignant cells that evade conventional treatment strategies by adapting to the hypoxic tumor microenvironment.
多细胞肿瘤球体常用于模拟无血管肿瘤内增殖的区域化和缺氧环境。在此,我们利用这些特征来研究DNA损伤修复途径的激活及其与缺氧发展的相关性。
使用免疫荧光、免疫组织化学、EdU掺入、蛋白质免疫印迹、彗星试验和药理试剂,在A673尤因肉瘤球体和单层培养物中研究DNA损伤修复标志物的激活、增殖、细胞死亡、糖原积累和缺氧发展情况。
在生长中的球体的缺氧、坏死周边区域观察到DNA损伤标志物γ-H2AX。虽然大多数增殖细胞见于球体表面,但在缺氧区域也有一些Ki-67阳性细胞。球体中缺氧诱导的H2AX磷酸化形成γ-H2AX被ATM抑制剂KU55933减弱,但未被ATR抑制剂VE-821减弱。
肿瘤球体模拟了实体瘤内的肿瘤微环境,如缺氧、低氧和有氧生态位,以及在这些不同微环境条件下存活、增殖和经历DNA损伤修复过程的细胞群体。在A673球体的缺氧核心中,ATM而非ATR是负责γ-H2AX形成的主要激酶。球体在测试旨在靶向通过适应缺氧肿瘤微环境而逃避传统治疗策略的恶性细胞的治疗方法方面可能具有独特优势。